HLB Co., Ltd. (028300) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for HLB Co., Ltd. (028300:KRX), powered by AI.
- Current Price
- ₩50,800
- P/E Ratio
- -30.7
- Market Cap
- 6.8T
- Sector
- Healthcare
What is the HLB Co., Ltd. stock price forecast?
HLB Co., Ltd. is currently trading at ₩50,800. View real-time AI analysis on Alpha Lenz.
What is HLB Co., Ltd. insider trading activity?
View the latest insider trading data for HLB Co., Ltd. on Alpha Lenz.
What is HLB Co., Ltd.'s P/E ratio?
HLB Co., Ltd.'s P/E ratio is -30.7.
HLB Co., Ltd.
KRX · 028300“HLB Co., Ltd. trades at a P/E of -30.7 (undervalued) with modest ROE of -44.3%.”
Ask for details →Company Overview
HLB Co., Ltd. manufactures and constructs lifeboats and glass fiber pipes in South Korea and internationally. It engages in the repair and inspection of lifeboats; fabrication and installation of pipes; development and manufacturing of biopharmaceuticals products, such as anti-cancer drugs; and manufacture and sale of medical devices, as well as manufacture and sale of quasi-drugs products, including alcohol swabs, sampling tools, etc. The company is also involved in e-commerce, investment, and financing activities. HLB Co., Ltd. was founded in 1975 and is headquartered in Ulsan, South Korea.
Company Statistics
FY 2025Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“HLB Co., Ltd. trades at a P/E of -30.7 (undervalued) with modest ROE of -44.3%.”
Ask for details →Frequently Asked Questions
HLB Co., Ltd. (ticker: 028300) is a company listed on KRX in the Healthcare sector (Biotechnology). It has approximately 160 employees. Market cap is $6.8T.
The current price is ₩50,800 with a P/E ratio of -30.69x and P/B of 16.17x.
ROE is -44.32% and operating margin is -117.16%. Annual revenue is $84.2B.